Post-translational regulations of PD-L1 and PD-1: Mechanisms and opportunities for combined immunotherapy
出版年份 2021 全文链接
标题
Post-translational regulations of PD-L1 and PD-1: Mechanisms and opportunities for combined immunotherapy
作者
关键词
PD-L1, PD-1, Immunotherapy, Post-translational modification, Ubiquitination, PROTAC, Glycosylation, Phosphorylation, Acetylation, Palmitoylation
出版物
SEMINARS IN CANCER BIOLOGY
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-04-06
DOI
10.1016/j.semcancer.2021.04.002
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1
- (2021) Adam D. Cotton et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Homogeneous, Low-volume, Efficient, and Sensitive Quantitation of Circulating Exosomal PD-L1 for Cancer Diagnosis and Immunotherapy Response Prediction
- (2020) Mengjiao Huang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- PROTACs: A novel strategy for cancer therapy
- (2020) Jing Liu et al. SEMINARS IN CANCER BIOLOGY
- Regulation of sister chromatid cohesion by nuclear PD-L1
- (2020) Jia Yu et al. CELL RESEARCH
- Loss of core fucosylation enhances the anticancer activity of cytotoxic T lymphocytes by increasing PD‐1 degradation
- (2020) Nianzhu Zhang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- RBR E3 ubiquitin ligases in tumorigenesis
- (2020) Peter Wang et al. SEMINARS IN CANCER BIOLOGY
- The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells
- (2020) Yu Wang et al. Cell Communication and Signaling
- Discovery of novel resorcinol diphenyl ether-based PROTAC-like molecules as dual inhibitors and degraders of PD-L1
- (2020) Binbin Cheng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Regulation of PD-1 in T cells for cancer immunotherapy
- (2020) Xibao Yu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Lysosome-targeting chimaeras for degradation of extracellular proteins
- (2020) Steven M. Banik et al. NATURE
- N‐glycosylation of PD‐1 promotes binding of camrelizumab
- (2020) Kefang Liu et al. EMBO REPORTS
- Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy
- (2020) Yang Gao et al. NATURE CELL BIOLOGY
- PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis
- (2020) Junwei Hou et al. NATURE CELL BIOLOGY
- Exosomal PD-L1: New Insights Into Tumor Immune Escape Mechanisms and Therapeutic Strategies
- (2020) Kaijian Zhou et al. Frontiers in Cell and Developmental Biology
- Deubiquitinating enzyme OTUB1 promotes cancer cell immunosuppression via preventing ER-associated degradation of immune checkpoint protein PD-L1
- (2020) Dan Zhu et al. CELL DEATH AND DIFFERENTIATION
- MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1
- (2019) Hui Li et al. GASTROENTEROLOGY
- Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory
- (2019) Mauro Poggio et al. CELL
- Camrelizumab: First Global Approval
- (2019) Anthony Markham et al. DRUGS
- IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion
- (2019) Li-Chuan Chan et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibition of mTOR complex 1/p70 S6 kinase signaling elevates PD-L1 levels in human cancer cells through enhancing protein stabilization accompanied with enhanced β-TrCP degradation
- (2019) Liang Deng et al. ONCOGENE
- USP22 Deubiquitinates CD274 to Suppress Anticancer Immunity
- (2019) Xing Huang et al. Cancer Immunology Research
- The Diverse Contributions of Fucose Linkages in Cancer
- (2019) Tyler S. Keeley et al. Cancers
- The Cancer Immunotherapy Biomarker Testing Landscape
- (2019) Eric E. Walk et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Advances in Discovering Deubiquitinating Enzyme (DUB) Inhibitors
- (2019) Nathan J. Schauer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients
- (2019) Chuling Li et al. Journal of Translational Medicine
- c-Cbl targets PD-1 in immune cells for proteasomal degradation and modulates colorectal tumor growth
- (2019) Chimera Lyle et al. Scientific Reports
- Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1
- (2018) Chia-Wei Li et al. CANCER CELL
- Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth
- (2018) Yi Yang et al. CELL RESEARCH
- Emerging Roles of DHHC-mediated Protein S -palmitoylation in Physiological and Pathophysiological Context
- (2018) Indranil De et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Regulation and Function of the PD-L1 Checkpoint
- (2018) Chong Sun et al. IMMUNITY
- Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
- (2018) Kristian M. Hargadon et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion
- (2018) Jung-Mao Hsu et al. Nature Communications
- Deubiquitination and stabilization of programmed cell death ligand 1 by ubiquitin-specific peptidase 9, X-linked in oral squamous cell carcinoma
- (2018) Wu Jingjing et al. Cancer Medicine
- Sensitive detection of exosomal proteins via a compact surface plasmon resonance biosensor for cancer diagnosis
- (2018) Chang Liu et al. ACS Sensors
- Palmitoylation is a post-translational modification of Alix regulating the membrane organization of exosome-like small extracellular vesicles
- (2018) Daniele P. Romancino et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1
- (2018) Jong-Ho Cha et al. MOLECULAR CELL
- Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
- (2018) Gang Chen et al. NATURE
- FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells
- (2018) Xiangbo Meng et al. NATURE
- Functions and mechanisms of non-histone protein acetylation
- (2018) Takeo Narita et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The Function of Fucosylation in Progression of Lung Cancer
- (2018) Liyuan Jia et al. Frontiers in Oncology
- Small-Molecule Sigma1 Modulator Induces Autophagic Degradation of PD-L1
- (2017) Christina M. Maher et al. MOLECULAR CANCER RESEARCH
- Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
- (2017) Riccardo Mezzadra et al. NATURE
- Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance
- (2017) Jinfang Zhang et al. NATURE
- CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
- (2017) Marian L. Burr et al. NATURE
- Ubiquitylation at the crossroads of development and disease
- (2017) Michael Rape NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- An unexpected N-terminal loop in PD-1 dominates binding by nivolumab
- (2017) Shuguang Tan et al. Nature Communications
- A regulatory role for the co-chaperone FKBP51s in PD-L1 expression in glioma
- (2017) Paolo D'Arrigo et al. Oncotarget
- Blockage of Core Fucosylation Reduces Cell-Surface Expression of PD-1 and Promotes Anti-tumor Immune Responses of T Cells
- (2017) Masahiro Okada et al. Cell Reports
- Identifying Regulatory Posttranslational Modifications of PD-L1: A Focus on Monoubiquitinaton
- (2017) Henrick Horita et al. NEOPLASIA
- Deubiquitination and Stabilization of PD-L1 by CSN5
- (2016) Seung-Oe Lim et al. CANCER CELL
- Communication by Extracellular Vesicles: Where We Are and Where We Need to Go
- (2016) Mercedes Tkach et al. CELL
- Post-Translational Modification Control of Innate Immunity
- (2016) Juan Liu et al. IMMUNITY
- Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family
- (2016) Frank A. Schildberg et al. IMMUNITY
- Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
- (2016) Jonathan M. Pitt et al. IMMUNITY
- The biology and function of exosomes in cancer
- (2016) Raghu Kalluri JOURNAL OF CLINICAL INVESTIGATION
- Genetic and Epigenetic Regulation of PD-1 Expression
- (2016) Alexander P. R. Bally et al. JOURNAL OF IMMUNOLOGY
- Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
- (2016) Chia-Wei Li et al. Nature Communications
- Acetylation modification regulates GRP78 secretion in colon cancer cells
- (2016) Zongwei Li et al. Scientific Reports
- Regulation of PD-L1: a novel role of pro-survival signalling in cancer
- (2015) J. Chen et al. ANNALS OF ONCOLOGY
- Ubiquitination as a Mechanism To Transport Soluble Mycobacterial and Eukaryotic Proteins to Exosomes
- (2015) Victoria L. Smith et al. JOURNAL OF IMMUNOLOGY
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Selective inhibitors of the FK506-binding protein 51 by induced fit
- (2014) Steffen Gaali et al. Nature Chemical Biology
- Post-Translational Modifications of Exosomal Proteins
- (2014) Olga Moreno-Gonzalo et al. Frontiers in Immunology
- Mechanisms and principles of N-linked protein glycosylation
- (2011) Flavio Schwarz et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now